Ohio Attorney General Mike DeWine today released concealed carry license statistics for the second quarter of 2013 reporting 48,032 concealed carry licenses were issued.
Ohio Attorney General Mike DeWine is requesting the public's help in locating a sex offender who is no longer compliant with Ohio's registration laws.
Ohio Attorney General Mike DeWine announced today that the Ohio Bureau of Criminal Investigation (BCI) and Ohio Peace Officer Training Academy (OPOTA) have both been reaccredited under the Commission on Accreditation for Law Enforcement Agencies' (CALEA) new Gold Standard Assessment process.
Ohio Attorney General Mike DeWine today filed a lawsuit charging Utah-based Vision Security LLC with misleading Ohio consumers and failing to honor their cancellation requests.
Ohio Attorney General Mike DeWine, Union County Sheriff Jamie Patton, and Marysville Police Chief Floyd Golden announced today a multi-jurisdictional internet café investigation spanning several Ohio counties.
In an effort to keep the public up-to-date on the progress of the Sexual Assault Kit (SAK) Testing Initiative, Attorney General Mike DeWine released a status update today.
Ohio Attorney General Mike DeWine today announced a lawsuit against NewKor, Inc., a manufacturing facility on Cleveland’s west side. Emissions from the facility allegedly are causing throat irritation, choking, and nausea for nearby residents.
Ohio Attorney General Mike DeWine announced today that a Richland County Grand Jury has indicted a Lexington, Ohio, couple for the improper use of more than $200,000 in scholarship funding.
As part of his Ohio Unsolved Homicides Initiative, Attorney General Mike DeWine is asking for information regarding a homicide in Lima that happened more than a decade ago.
Ohio Attorney General Mike DeWine announced today that Ohio has joined with other states and the federal government in a settlement of $491 million to resolve civil and criminal allegations that Wyeth Pharmaceuticals, Inc. promoted the sale and use of the drug Rapamune for uses for which it had not been approved by the U.S. Food and Drug Administration (FDA).